Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Accuracy of the FMF Bayes theorem-based model for predicting preeclampsia at 11–13 weeks of gestation in a Japanese population

A Correction to this article was published on 09 April 2021

A Correction to this article was published on 08 February 2021

A Correction to this article was published on 23 December 2020

This article has been updated

Abstract

This study aimed to investigate the diagnostic accuracy of the Fetal Medicine Foundation (FMF) Bayes theorem-based model for the prediction of preeclampsia (PE) at 11–13 weeks of gestation in the Japanese population. In this prospective cohort study, we invited 2655 Japanese women with singleton pregnancies at 11–13 weeks of gestation to participate, of whom 1036 women provided written consent. Finally, we included 913 women for whom all measurements and perinatal outcomes were available. Data on maternal characteristics and medical history were recorded. Mean arterial pressure (MAP), uterine artery pulsatility index, and maternal serum placental growth factor (PlGF) were measured. The patients delivered their babies at Showa University Hospital between June 2017 and December 2019. Participants were classified into high- and low-risk groups according to the FMF Bayes theorem-based model. Frequencies of PE were compared between groups. The screening performance of the model was validated using the area under receiver operating characteristic (AUROC) curve. A total of 26 patients (2.8%) developed PE, including 11 patients (1.2%) with preterm PE (delivery at <37 weeks). The frequency of preterm PE was significantly higher in the high-risk group than in the low-risk group (3.8% vs. 0.2%, p < 0.05). This population model achieved a 91% detection rate for the prediction of preterm PE at a screen-positive rate of 10% by a combination of maternal characteristics, MAP, and PlGF. The AUROC curve for the prediction of preterm PE was 0.962 (0.927–0.981). In conclusion, the prediction of preterm PE using the FMF Bayes theorem-based model is feasible in the Japanese population.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

Change history

References

  1. Bujold E, Roberge S, Lacasse Y, Bureau M, Audibert F, Marcoux S, et al. Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis. Obstet Gynecol. 2010;116:402–414.

    Article  Google Scholar 

  2. Rolnik DL, Wright D, Poon LC, O’Gorman N, Syngelaki A, de Paco Matallana C, et al. Aspirin versus placebo in pregnancies at hight risk for preterm preeclampsia. N. Engl J Med. 2017;377:613–622.

    Article  CAS  Google Scholar 

  3. Wright D, Rolnik DL, Syngelaki A, de Paco Matallana C, Machuca M, de Alvarado M, et al. Aspirin for evidence-based preeclampsia prevention trial: effect of aspirin on length of stay in the neonatal intensive care unit. Am J Obstet Gynecol. 2018;218:612.e1–612.e6.

    Article  CAS  Google Scholar 

  4. O’Gorman N, Wright D, Syngelaki A, Akolekar R, Wright A, Poon LC, et al. Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 11–13 weeks gestation. Am J Obstet Gynecol. 2016;214:103.e1–103.e12.

    Article  Google Scholar 

  5. Krantz DA, Hallahan TW. Incorporating the probability of competing event(s) into the preeclampsia competing risk algorithm. Am J Obstet Gynecol. 2019;221:533–4.

    Article  Google Scholar 

  6. Chaemsaithong P, Pooh RK, Zheng M, Ma R, Chaiyasit N, Tokunaka M, et al. Prospective evaluation of screening performance of first trimester prediction models for preterm preeclampsia in an Asian population. Am J Obstet Gynecol. 2019;221:650.e1–650.e16.

    Article  Google Scholar 

  7. Wright D, Syngelaki A, Akolekar R, Poon LC, Nicolaides KH. Competing risks model in screening for preeclampsia by maternal characteristics and medical history. Am J Obstet Gynecol. 2015;213:62.e1–62.e10.

    Article  Google Scholar 

  8. Poon LC, Zymeri NA, Zamprakou A, Syngelaki A, Nicolaides KH. Protocol for measurement of mean arterial pressure at 11–13 weeks gestation. Fetal Diagn Ther. 2012;31:42–48.

    Article  CAS  Google Scholar 

  9. Khalil A, Nicolaides KH. How to record uterine artery Doppler in the first trimester. Ultrasound Obstet Gynecol. 2013;42:478–479.

    CAS  PubMed  Google Scholar 

  10. Rolnik DL, da Silva Costa F, Sahota D, Hyett J, McLennan A. Quality assessment of uterine artery Doppler measurement in first-trimester combined screening for pre-eclampsia. Ultrasound Obstet Gynecol. 2019;53:245–50.

    Article  CAS  Google Scholar 

  11. Sato K. A proposal for a new definition and classification of “Pregnancy induced Hypertension (PIH)” (2004). In: Japan Society for the Study of Toxemia of Pregnancy (ed), Historical Perspective of Study of Pregnancy-Induced Hypertension in Japan Tokyo. Tokyo, Japan: Medical View Co; 2005. p. 54–87.

  12. Watanabe K, Naruse K, Tanaka K, Metoki H, Suzuki Y. Outline of definition and classification of “Pregnancy induced Hypertension (PIH)”. Hypertens Res Pregnancy. 2013;1:3–4.

    Article  Google Scholar 

  13. O’Gorman N, Wright D, Poon LC, Rolnik DL, Syngelaki A, de Alvarado M, et al. Multicenter screening for pre-eclampsia by maternal factors and biomarkers at 11–13 weeks gestation: comparison with NICE guidelines and ACOG recommendations. Ultrasound Obstet Gynecol. 2017;49:756–760.

    Article  Google Scholar 

  14. Wright A, Wright D, Syngelaki A, Georgantis A, Nicolaides KH. Two-stage screening for preterm preeclampsia at 11–13 weeks gestation. Am J Obstet Gynecol. 2019;220:197.E1–197.E11.

    Article  Google Scholar 

  15. Tong J, Niu Y, Chen ZJ, Zhang C. Comparison of the transcriptional profile in the decidua of early-onset and late-onset pre-eclampsia. J Obstet Gynecol Res. 2020;46:1055–1066.

    Article  CAS  Google Scholar 

  16. Roberts JM, Hubel CA. The two stage model of preeclampsia: variations on the theme. Placenta. 2009;30:S32–S37.

    Article  Google Scholar 

  17. Brunelli E, Seidenari A, Germano C, Prefumo F, Cavoretto P, Di Martino D, et al. External validation of a simple risk score based on the ASPRE trial algorithm for preterm pre-eclampsia considering maternal characteristics in nulliparous pregnant women: a multicenter retrospective cohort study. BJOG. 2020;127:1210–5.

    Article  CAS  Google Scholar 

  18. Di Martino D, Masturzo B, Paracchini S, Bracco B, Cavoretto P, Prefumo F, et al. Comparison of two “a priori” risk assessment algorithms for preeclampsia in Italy: a prospective multicenter study. Arch Gynecol Obstet. 2019;299:1587–96.

    Article  Google Scholar 

Download references

Acknowledgements

This study was supported by a Grant-in-Aid for Scientific Research (C) (No. 19K18653) from the Japan Society for the Promotion of Science. We kindly thank all the participants, obstetricians, nurses, and research assistants employed in this study. This work was supported by the PerkinElmer Company (Waltham, MA, USA), which provided the database. Supplementary information is available at the Hypertension Research website.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Minako Goto.

Ethics declarations

Conflict of interest

PCL has received speaker fees and consultancy payments from Roche Diagnostics, Ferring Pharmaceuticals, and GE Healthcare and in-kind contributions from Roche Diagnostics, PerkinElmer, Thermo Fisher Scientific, and GE Healthcare. The other authors report no conflicts of interest.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

The original online version of this article was revised: plus the same explanatory text of the problem as in the erratum/correction article.

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Goto, M., Koide, K., Tokunaka, M. et al. Accuracy of the FMF Bayes theorem-based model for predicting preeclampsia at 11–13 weeks of gestation in a Japanese population. Hypertens Res 44, 685–691 (2021). https://doi.org/10.1038/s41440-020-00571-4

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41440-020-00571-4

Keywords

This article is cited by

Search

Quick links